ReviewProteomics. Clinical applications2013

Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Hussein Yassine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.